Back to search

Article

Auranofin Inhibits Hepatitis E Virus Replication Via Reactive Oxygen Species

2025-05-02

Abstract excerpt

Hepatitis E virus (HEV) causes roughly 20 million yearly global infections, and is associated with chronic hepatitis, neurological sequelae and pregnancy-related adverse outcomes that require antiviral therapeutic intervention. While there are currently no approved HEV-specific therapeutics, ribavirin and pegylated interferon, prescribed off-label, are the current standard of care. However, ribavirin resistance an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d91f81e6-f6e1-57c8-856b-2aac2123f00d
DOI
10.1101/2025.05.02.651833
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Auranofin Inhibits Hepatitis E Virus Replication Via Reactive Oxygen SpeciesDOI 10.1101/2025.05.02.651833
Select a neighboring publication to make it the new centre.